Galena Biopharma (GALE) Reports In-Line Q3 Loss of 9c/Share

Galena Biopharma (NASDAQ: GALE) reported Q3 EPS of ($0.09), in-line with the analyst estimate of ($0.09).

For earnings history and earnings-related data on Galena Biopharma (GALE) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• TJX Cos. (TJX) Tops Q2 EPS by 3c, Beats on Revenue; Offers FY27 EPS Guidance
• Full Truck Alliance (YMM) Tops Q2 EPS by 10c; beats on guidance
• ZTO Express (ZTO) Tops Q2 EPS by 379c